Download PDF
Thromb Haemost 2006; 95(04): 735-737
DOI: 10.1160/TH04-12-0827
Case Report
Schattauer GmbH

Acquired haemophilia A: Successful treatment with immunosuppression, methylprednisolone pulses and oral cyclosporin

José Pardos-Gea
1   Department of Internal Medicine and
,
José Ordi-Ros
1   Department of Internal Medicine and
,
Carmen Altisent
1   Department of Internal Medicine and
,
Eva Balada
1   Department of Internal Medicine and
,
Jorge Pérez-López
1   Department of Internal Medicine and
,
Miquel Vilardell
1   Department of Internal Medicine and
› Author Affiliations
Further Information

Publication History

Received 20 December 2004

Accepted after resubmission 05 February 2006

Publication Date:
30 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Green D, Lechner K. A survey of 215 non-haemophilic patients with inhibitors to factor III. Thromb Haemost 1981; 45: 200-3.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Hauser I, Schneider B, Lechner K. Postpartum factor VIII inhibitors. Thromb Haemost 1995; 73: 1-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Sallah S, Wan JY. Inhibitors against Factor VIII in patients with cancer. Analysis of 41 patients. Cancer 2001; 91: 1067-74.
    CrossrefPubMedGoogle Scholar
  • 4 Pruthi RK, Nochols WL. Autoimmune factor VIII inhibitors. Curr Op Hematol 1999; 06: 314-22.
    PubMedGoogle Scholar
  • 5 Kasper CK, Aledort LM, Aronson D. et al. Proceedings :A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 34: 612.
    PubMedGoogle Scholar
  • 6 Lottenberg R, Kentro TB, Kitchens CS. Acquired haemophilia:A natural study on 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Inter Med 1987; 147: 1077-81.
    CrossrefPubMedGoogle Scholar
  • 7 Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicenter study. Thromb Haemost 1997; 78: 1463-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Delgado J, Jimenez-Yuste V, Hernández-Navarro F. et al. Acquired haemophilia: Review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003; 121: 21-35.
    CrossrefPubMedGoogle Scholar
  • 9 Hart HC, Kraijenhagen RJ, Kerckhaert JAM. et al. A patient with spontaneous factor VIII:C autoantibody:successful treatment with cyclosporine. Transplant Proc 1988; 20 (Suppl. 04) 323-8.
    PubMedGoogle Scholar
  • 10 Pflieger G, Boda Z, Harsfalvi J. et al. Cyclosporine treatment of a woman with acquired haemophilia due to factor VIII:C inhibitor. Postgrad Med J 1989; 65: 400-2.
    CrossrefPubMedGoogle Scholar
  • 11 Siegbahn A, Feltelius N, Norlen BJ. et al. Treatment of acquired haemophilia due to FVIII:C auto antibodies with recombinant FVIIa and cyclosporin. Thromb Haemost 1995; 73: 1424.
    PubMedGoogle Scholar
  • 12 McLeod BC, McKenna R, Chediak J. Treatment of acquired factor VIII inhibitors with antibody removal by aphresis followed by immunosuppression with prednisone and cyclosporine. Blood 1989; 74: 39.
    PubMedGoogle Scholar
  • 13 Shulman S, Langevithz P, Livneh A. et al. Cyclosporin therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus. Thromb Haemost 1996; 76: 344-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Brox AG, Laryea H, Pelletier M. Successful treatment of acquired factor VIII inhibitors with cyclosporin. Am J Hematol 1998; 57: 87-8.
    CrossrefPubMedGoogle Scholar
  • 15 Petrovic M, Derom E, Baele G. Cyclosporine treatment of acquired haemophilia due to factor VIII antibodies. Haematologica 2000; 85: 895-6.
    PubMedGoogle Scholar
  • 16 Saxena R, Mishra DK, Kashyap R. et al. Acquired haemophilia-a study of ten cases. Haemophilia 2000; 06: 78-83.
    CrossrefPubMedGoogle Scholar
  • 17 Sueiras M, Gonzalez N, Rovira R. et al. Usefulness of the EEG recording in the diagnosis of cyclosporin A- induced encephalopathy. Rev Neurol 1998; 26: 766-9.
    PubMedGoogle Scholar
  • 18 Pruthi RK, Nickols WL. Autoinmune factor VIII inhibitors. Curr Opin Hematol 1999; 06: 314-22.
    CrossrefPubMedGoogle Scholar
  • 19 Green D, Rademaker AW, Briet E. A randomised trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII auto antibodies. Thromb Heamost 1993; 70: 753-7.
    PubMedGoogle Scholar
  • 20 Spero JA, Lewis JH, Hasiba U. Corticosteroid therapy for acquired FBI:C inhibitors. Br J Haematol 1981; 48: 635-42.
    PubMedGoogle Scholar
  • 21 Bossi P, Cabane J, Ninet J. et al. Acquired haemophilia due to factor VIII inhibitors in 34 patients. Am J Med 1998; 105: 400-8.
    CrossrefPubMedGoogle Scholar
  • 22 Schwart R, Gabriel DA, Alerdort LM. et al. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gamma globulin. Blood 1995; 86: 797-804.
    PubMedGoogle Scholar
  • 23 Schwerdtfeger R, Hintz G, Huhn D. Successful treatment of a patient with postpartum factor VIII inhibitors with recombinant human interferon a2. Am J Hematol 1991; 37: 190-3.
    CrossrefPubMedGoogle Scholar
  • 24 Slocombe GW, Newland AC, Colvin MP. et al. The role of intensive plasma exchange in the prevention and management of haemorrhage in patients with inhibitors to factor VIII. Br J Haematol 1981; 47: 577-85.
    CrossrefPubMedGoogle Scholar
  • 25 Stasi R, Brunetti M, Stipa E. et al. Selective B-cell depletion with rituximab for the treatment of patients with acquired haemophilia. Blood 2004; 103: 4424-8.
    CrossrefPubMedGoogle Scholar